Company Filing History:
Years Active: 2007
Title: Gerlinde Lenzen: Innovator in Mammalian Receptor Research
Introduction
Gerlinde Lenzen is a prominent inventor based in Paris, France. She has made significant contributions to the field of biochemistry, particularly in the study of mammalian receptors. Her innovative work has led to the development of a unique polypeptide that has potential applications in various medical fields.
Latest Patents
Gerlinde Lenzen holds a patent for the invention titled "Mammalian ICYP (iodocyanopindolol) receptor and its applications." This patent describes an isolated and substantially pure mammalian polypeptide that is distinct from known adrenergic, serotonin, and dopamine receptors. The polypeptide is found on mammalian muscle and eosinophil membranes, including those in rats, guinea pigs, and humans. The invention also encompasses plasmids containing the genes coding for this polypeptide, transformed host cells, nucleotide probes for hybridization, and antibodies directed against the polypeptide. The polypeptide exhibits specific binding characteristics and molecular weight properties, making it a valuable asset in receptor research.
Career Highlights
Gerlinde Lenzen has had a successful career in the pharmaceutical industry, currently working at Dainippon Sumitomo Pharma Co., Ltd. Her research has been pivotal in advancing our understanding of non-adrenergic receptors and their potential therapeutic applications.
Collaborations
Throughout her career, Gerlinde has collaborated with notable colleagues, including Arthur Donny Strosberg and Toshinari Sugasawa. These partnerships have further enriched her research and contributed to the advancement of receptor studies.
Conclusion
Gerlinde Lenzen's innovative work in the field of mammalian receptors highlights her significant contributions to biochemistry and pharmacology. Her patent on the ICYP receptor opens new avenues for research and potential medical applications.